Aron Chakera

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 215 citations · Full text

Medicine, Internal Medicine, Nephrology +12

Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression

Aron Chakera, Clare MacEwen, Shubha S. Bellur et al. · Journal of Nephrology · 2015 · 90 citations

Medicine, Nephrology, Pathology +13

The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization

Aron Chakera, Ruth M. Seeber, Alison E. John et al. · Molecular Pharmacology · 2008 · 88 citations

Life Sciences, Immunology, Molecular Biology +16

Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

Frank B. Cortazar, John L. Niles, David Jayne et al. · Kidney International Reports · 2023 · 85 citations · Full text

Medicine, Internal Medicine, Nephrology +16

Renal Transplant Immunosuppression Impairs Natural Killer Cell Function In Vitro and In Vivo

Olivier Morteau, Samkeliso Blundell, Aron Chakera et al. · PLoS ONE · 2010 · 72 citations · Full text

Life Sciences, Immunology, Nephrology +17